Analyst Consensus ?
ConsensusHold22 ratings
Bullish1150.0%
Neutral1045.5%
Bearish14.5%
Evercore Inc. · EVR · FY2025 Q4 · Calendar Q1 2026
Evercore’s 2025 momentum carried into Q4, with growth and market-share gains
The supplied results and transcript analysis support a constructive view of Evercore’s operating momentum: earnings and revenue exceeded estimates, while the 2025 narrative emphasized recovering M&A activity and a broader revenue mix. That case remains exposed to deal-cycle volatility, expense growth, and the challenge of sustaining large-cap deal flow; the available current-quarter analysis does not provide formal guidance.
Reported Before market openNYSEFinancial Services
$11.17B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$5.13
Consensus $3.83
EPS surprise
+33.9%
Reported versus consensus
Reported revenue
$1.30B
Consensus $1.12B
Revenue surprise
+15.8%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+5.2%
Event window
SPY move
-0.5%
Same window
Abnormal move
+5.7%
Stock minus SPY
Volume
2.3×
Versus trailing sessions
Subsequent drift
-15.0%
Up to 20 sessions
EVRSPY benchmark
Ask FN2 about EVR FY2025 Q4
Transcript, numbers and history already loaded
Why did EVR rise 5.2% after beating EPS estimates in FY2025 Q4?What changed in EVR's guidance and outlook in FY2025 Q4?Give me the bull and bear case for EVR after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
FY2025 Q4 results came in above consensus estimates for both EPS and revenue. Relative to the prior-quarter analysis, the supplied current analysis puts greater emphasis on 2025 record results, recovery in large-cap M&A, EMEA expansion, and capabilities in debt advisory, securitization, and ratings advisory. The current analysis does not provide a formal outlook.
Guidance delta
No formal guidance was provided in the supplied FY2025 Q4 analysis, so a guidance change cannot be assessed.
Key takeaways
- EPS and revenue exceeded consensus estimates in FY2025 Q4.
- The current analysis cites a rebound in M&A, including large-cap deals, as a key growth driver.
- Diversified revenue, including private capital advisory and secondary-market activity, remains central to the growth narrative.
- Expansion in EMEA and broader advisory capabilities are management priorities in the supplied analysis.
Management priorities
- Expand the EMEA footprint, including offices in Italy, the Nordics, and Saudi Arabia.
- Build debt advisory, securitization, and ratings advisory capabilities.
- Continue senior-talent recruitment and internal promotions, alongside technology investment.
- Maintain share repurchases to offset dilution from RSU grants.
Follow EVR with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$290.5Current
$109Low
$339.8Average
$870High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 2, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 29, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 1, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 3, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Jul 30, 2026 |
| JMP Securities | Market Perform | Market Outperform | Downgrade | Jul 14, 2025 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 11, 2025 |
| Evercore ISI Group | Sell | Neutral | Downgrade | Sep 23, 2022 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 8, 2022 |
| Seaport Global | Buy | Buy | Maintain | Dec 16, 2020 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 9, 2020 |
| Bank of America | Buy | Buy | Maintain | Jun 26, 2018 |
| B of A Securities | Buy | Buy | Maintain | Jun 26, 2018 |
| Nomura | Neutral | Neutral | Maintain | Nov 3, 2017 |
| Craig-Hallum | Hold | Buy | Downgrade | Mar 16, 2016 |
| Susquehanna | Neutral | Positive | Downgrade | Nov 10, 2015 |
| Credit Suisse | Outperform | Outperform | Maintain | Sep 8, 2015 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | Jul 8, 2015 |
| Macquarie | Outperform | Outperform | Maintain | Nov 25, 2014 |
| Sandler O'Neill | Buy | Hold | Upgrade | Jun 25, 2014 |
| S&P Capital IQ | Buy | Hold | Upgrade | Dec 30, 2013 |
| Bank oferica | Neutral | Neutral | Maintain | Apr 9, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $290.5. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $357 | $292.38 | +22.9% | Oct 28, 2026 |
| Evercore ISI | Mark Mahaney | $870 | $252.01 | +199.5% | Oct 22, 2026 |
| Morgan Stanley | Analyst unavailable | $315 | $267.26 | +8.4% | Oct 8, 2026 |
| Evercore ISI | Analyst unavailable | $150 | $262.42 | -48.4% | Oct 7, 2026 |
| UBS | Analyst unavailable | $318 | $268.08 | +9.5% | Oct 7, 2026 |
| Goldman Sachs | Analyst unavailable | $331 | $257.5 | +13.9% | Oct 1, 2026 |
| Evercore ISI | Mark Mahaney | $860 | $287.92 | +196.0% | Sep 10, 2026 |
| BMO Capital | Brennan Hawken | $338 | $320.56 | +16.4% | Aug 3, 2026 |
| Morgan Stanley | Analyst unavailable | $363 | $310.16 | +25.0% | Jul 30, 2026 |
| Morgan Stanley | Analyst unavailable | $389 | $304.71 | +33.9% | Jul 30, 2026 |
| Evercore ISI | Mark Mahaney | $820 | $304.71 | +182.3% | Jul 30, 2026 |
| Goldman Sachs | Analyst unavailable | $376 | $304.71 | +29.4% | Jul 29, 2026 |
| UBS | Analyst unavailable | $350 | $337.96 | +20.5% | Jul 8, 2026 |
| Evercore ISI | Mark Mahaney | $930 | $367.04 | +220.1% | Jun 17, 2026 |
| Morgan Stanley | Analyst unavailable | $376 | $318.03 | +29.4% | Apr 30, 2026 |
| UBS | Analyst unavailable | $330 | $319.47 | +13.6% | Apr 30, 2026 |
| Goldman Sachs | James Yaro | $374 | $350.54 | +28.7% | Apr 14, 2026 |
| Morgan Stanley | Analyst unavailable | $384 | $334.96 | +32.2% | Apr 9, 2026 |
| RBC Capital | Analyst unavailable | $420 | $348.59 | +44.6% | Feb 5, 2026 |
| UBS | Analyst unavailable | $383 | $356.36 | +31.8% | Feb 5, 2026 |
| Morgan Stanley | Analyst unavailable | $381 | $354.21 | +31.2% | Feb 4, 2026 |
| Evercore ISI | David Motemaden | $390 | $338.73 | +34.3% | Feb 3, 2026 |
| Evercore ISI | Analyst unavailable | $435 | $362 | +49.7% | Jan 26, 2026 |
| Wolfe Research | Analyst unavailable | $406 | $374.91 | +39.8% | Jan 7, 2026 |
| UBS | Michael Brown | $363 | $371.26 | +25.0% | Jan 7, 2026 |
| Goldman Sachs | Analyst unavailable | $413 | $351.27 | +42.2% | Jan 5, 2026 |
| UBS | Michael Brown | $340 | $344.78 | +17.0% | Dec 11, 2025 |
| Evercore ISI | David Motemaden | $387 | $338.02 | +33.2% | Dec 10, 2025 |
| Morgan Stanley | Analyst unavailable | $373 | $331.69 | +28.4% | Dec 8, 2025 |
| Evercore ISI | Mark Mahaney | $875 | $292.49 | +201.2% | Oct 30, 2025 |
| Evercore ISI | Analyst unavailable | $400 | $318 | +37.7% | Oct 8, 2025 |
| Wolfe Research | Steven Chubak | $311 | $274.88 | +7.1% | Jan 3, 2025 |
| Evercore ISI | Kenneth Leon | $250 | $238.93 | -13.9% | Sep 13, 2024 |
| Goldman Sachs | James Yaro | $276 | $233.88 | -5.0% | Sep 10, 2024 |
| Goldman Sachs | James Yaro | $251 | $236.39 | -13.6% | Jul 24, 2024 |
| Morgan Stanley | Analyst unavailable | $102 | $134.23 | -64.9% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $94 | $126.73 | -67.6% | Jan 12, 2023 |
| Goldman Sachs | Analyst unavailable | $125 | $125.09 | -57.0% | Jan 11, 2023 |
| UBS | Analyst unavailable | $95 | $122.12 | -67.3% | Jan 9, 2023 |
| Evercore ISI | Matthew Moon | $126 | $109.08 | -56.6% | Jan 2, 2023 |
| Evercore ISI | Michael Brown | $109 | $99.65 | -62.5% | Oct 27, 2022 |
| Morgan Stanley | Analyst unavailable | $97 | $92.81 | -66.6% | Jul 19, 2022 |
Track every rating change on EVR the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEvercore Inc. functions as an autonomous investment banking advisory firm, maintaining a substantial international presence with operations spanning the United States, Europe, and Latin America. The company is structured into two core business units: Investment Banking and Investment Management. Its Investment Banking division provides extensive strategic guidance, covering mergers and acquisitions, corporate strategic planning, defense advisory, shareholder relations, special committee engagements, and complex transaction structuring.…
Historical context
All EVR earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CBOE Cboe Global Markets, Inc. | FY2026 Q3 · Calendar Q4 2026 | +5.8% | +6.8% | Cboe posts strong Q3 as options growth and new products advance |
| NWG NatWest Group plc | FY2026 Q3 · Calendar Q4 2026 | +2.0% | -9.0% | NatWest maintains guidance as Q3 growth and capital remain strong |
| ERIE Erie Indemnity Company | FY2026 Q3 · Calendar Q4 2026 | +2.1% | +5.3% | Erie pairs resilient demand initiatives with thin underwriting margins |
| COIN Coinbase Global, Inc. | FY2026 Q3 · Calendar Q4 2026 | +1189.2% | -10.6% | Coinbase offsets lower spot trading with prediction markets and AI agents |
| TPG TPG Inc. | FY2026 Q3 · Calendar Q4 2026 | +4.3% | +7.5% | TPG raises FRE margin outlook as capital formation accelerates |
| AJG Arthur J. Gallagher & Co. | FY2026 Q3 · Calendar Q4 2026 | +0.3% | +2.9% | AJG: Q3 growth and AssuredPartners synergies support outlook |
Latest beats and misses
Who reports nextBeat on EPS
- CHDFY2026 Q3 · October 30, 2026+2.2% EPS+1.2% move
- AZNFY2026 Q3 · October 30, 2026+7.3% EPS+7.0% move
- FRTFY2026 Q3 · October 30, 2026+3.9% EPS-1.1% move
- CVXFY2026 Q3 · October 30, 2026+8.4% EPS+1.8% move
- BTSGFY2026 Q3 · October 30, 2026+14.2% EPS+11.1% move
- EXCFY2026 Q3 · October 30, 2026+10.4% EPS+0.5% move
Missed on EPS
- GLPIFY2026 Q3 · October 29, 2026-11.5% EPS-1.3% move
- LYBFY2026 Q3 · October 30, 2026-1.2% EPS+5.0% move
- CCJFY2026 Q3 · October 30, 2026-101.4% EPS-7.9% move
- VALEFY2026 Q3 · October 29, 2026-24.6% EPS+1.9% move
- DLR-PLFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLR-PKFY2026 Q3 · October 29, 2026-8.4% EPS— move
Get the EVR recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-11-02T04:50:42.011344+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-02T04:50:42.008459+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-02. For educational purposes only; not investment advice.